Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021-Reference-Cited by-同舟云学术

Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021

Published:2022 Issue:4 Volume:69 Page:327-359
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Naruse Mitsuhide¹,Katabami Takuyuki²,Shibata Hirotaka³,Sone Masakatsu⁴,Takahashi Katsutoshi⁵,Tanabe Akiyo⁶,Izawa Shoichiro⁷,Ichijo Takamasa⁸,Otsuki Michio⁹,Omura Masao¹⁰,Ogawa Yoshihiro¹¹,Oki Yutaka¹²,Kurihara Isao¹³,Kobayashi Hiroki¹⁴,Sakamoto Ryuichi¹⁵,Satoh Fumitoshi¹⁶,Takeda Yoshiyu¹⁷,Tanaka Tomoaki¹⁸,Tamura Kouichi¹⁹,Tsuiki Mika²⁰,Hashimoto Shigeatsu²¹,Hasegawa Tomonobu²²,Yoshimoto Takanobu²³,Yoneda Takashi²⁴,Yamamoto Koichi²⁵,Rakugi Hiromi²⁵,Wada Norio²⁶,Saiki Aya²⁷,Ohno Youichi²⁸,Haze Tatsuya¹⁹

Affiliation:

1. Endocrine Center and Clinical Research Center, Ijinkai Takeda General Hospital, Kyoto 601-1495, Japan

2. Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University, Yokohama City Seibu Hospital, Yokohama 241-0811, Japan

3. Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan

4. Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University, Kawasaki 216-8511, Japan

5. Division of Metabolism, Showa General Hospital, Kodaira, 187-8510 Japan

6. Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Tokyo 162-8655, Japan

7. Division of Endocrinology and Metabolism, Tottori University Faculty of Medicine, Yonago 683-8504, Japan

8. Department of Diabetes and Endocrinology, Saiseikai Yokohamashi Tobu Hospital, Yokohama 230-0012, Japan

9. Department of Endocrinology, Tokyo Women’s Medical University, Tokyo 162-8666, Japan

10. Minato Mirai Medical Square, Yokohama, 220-0012 Japan

11. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan

12. Department of Metabolism and Endocrinology, Hamamatsu Kita Hospital, Hamamatsu 431-3113, Japan

13. Department of Medical Education, National Defense Medical College, Tokorozawa 359-8513, Japan

14. Division of Nephrology, Hypertension and Endocrinology, Nihon University School of Medicine, Tokyo 173-8610, Japan

15. Department of Endocrine and Metabolic Diseases/Diabetes Mellitus, Kyushu University Hospital, Fukuoka 812-8582, Japan

16. Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan

17. Department of Endocrinology and Metabolism, Kanazawa University Hospital, Kanazawa 920-8641, Japan

18. Department of Molecular Diagnosis, Chiba University, Chiba 260-8677, Japan

19. Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan

20. Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan

21. Department of Endocrinology, Metabolism, Diabetology and Nephrology, Fukushima Medical University Aizu Medical Center, Aizu 969-3492, Japan

22. Department of Pediatrics, Keio University School of Medicine, Tokyo 160-0016, Japan

23. Department of Diabetes and Endocrinology, Tokyo Metropolitan Hiroo Hospital, Tokyo 150-0013, Japan

24. Department of Health Promotion and Medicine of the Future, Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-8641, Japan

25. Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

26. Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo 060-8604, Japan

27. Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

28. Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/69/4/69_EJ21-0508/_pdf

Reference189 articles.

1. 1 Conn JW (1955) Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45: 3–17.

2. 2 Young WF Jr (2019) Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med 285: 126–148.

3. 3 Funder J (2020) Primary aldosteronism: treatment of the disease, and new therapeutic approaches. Best Pract Res Clin Endocrinol Metab 34: 101368.

4. 4 Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, et al. (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101: 1889–1916.

5. 5 Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, et al. (2011) Guidelines for the diagnosis and treatments of primary aldosteronism—the Japan Endocrine Society 2009. Endocr J 58: 711–721.

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bilateral superselective adrenal artery embolization for bilateral primary aldosteronism: a novel approach in an efficacy and safety proof-of-principle trial;Hypertension Research;2024-09-11

2. Soluble αKlotho concentration in the inferior vena cava of patients with primary aldosteronism;Nefrología;2024-09

3. Clinical benefits and uncertainties of treatment with esaxerenone in primary aldosteronism;Hypertension Research;2024-08-29

4. Safety and efficacy of bilateral superselective adrenal arterial embolization for treatment of idiopathic hyperaldosteronism: a prospective single-center study;BMC Surgery;2024-08-24

5. Historical changes in the clinical features of primary aldosteronism;Hypertension Research;2024-08-08